Our consultancy service offers an insight into the biomarker strategies currently applied within large Pharma. We can help formulate tailored translational biomarker strategies for your specific programs and advise on best practices for implementation with key outcomes including early identification of clear Go / No-Go decision points and increased confidence of a positive outcome in the clinic.
Biomarker Strategy Plan
Assistance with generation of a tailored Biomarker Strategy Plan (BSP) for your research programs. As with current practices in large Pharma, a BSP documents the key strategies associated with a program and further acts as management tool in the implementation, coordination, tracking and review of such strategies from early pre-clinical through to proof of concept.